Evidence map›Paper›PMID 39524625›Full record

ArticleACS omega2024

One-Pot Hybridization of Microfibrillated Cellulose and Hydroxyapatite as a Versatile Route to Eco-Friendly Mechanical Materials.

Yui Okuda, Ryosuke Sasaki, Eiichi Kido, Ken Hirota, Tadashi Mizutani

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Hydroxyapatite-cellulose composites: properties, fabrication methods, and applications.Journal of materials science. Materials in medicine · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yui OkudaDepartment of Applied Chemistry, Graduate School of Science and Engineering, Doshisha University, 1-3, Tatara-miyakotani, Kyotanabe, Kyoto 610-0394, Japan.
Ryosuke SasakiDepartment of Applied Chemistry, Graduate School of Science and Engineering, Doshisha University, 1-3, Tatara-miyakotani, Kyotanabe, Kyoto 610-0394, Japan.
Eiichi KidoDepartment of Applied Chemistry, Graduate School of Science and Engineering, Doshisha University, 1-3, Tatara-miyakotani, Kyotanabe, Kyoto 610-0394, Japan.
Ken HirotaDepartment of Applied Chemistry, Graduate School of Science and Engineering, Doshisha University, 1-3, Tatara-miyakotani, Kyotanabe, Kyoto 610-0394, Japan.
Tadashi MizutaniDepartment of Applied Chemistry, Graduate School of Science and Engineering, Doshisha University, 1-3, Tatara-miyakotani, Kyotanabe, Kyoto 610-0394, Japan.ORCID https://orcid.org/0000-0003-4482-264X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydroxyapatite was crystallized in an alkaline dispersion of mechanically fibrillated cellulose to prepare their composites with hydroxyapatite contents of 26-86 wt %. The composite powder was uniaxially pressed at 120 °C and 300 MPa to obtain the compacts. Three-point bending tests revealed that the bending strengths of the compacts were 40-100 MPa, and the elastic moduli were 4-9 GPa. The composite containing 43% hydroxyapatite showed the largest bending strength and the largest work of fracture, and the composite containing 62% hydroxyapatite showed the largest elastic modulus. The composites, derived from the bioderived eco-friendly materials, showed the mechanical properties comparable to those of engineering plastics such as polyamide-6. Scanning electron microscopic observation of the fracture surface showed that the organic phase was discontinuous when the hydroxyapatite weight fraction was increased from 43% to 62%, and the compacts with a discontinuous organic phase lost toughness.

Identifiers

PMID39524625
PMCPMC11541509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.